PPIG and Cirrhosis: The developed model successfully predicted human PK and evaluated the effects of extrinsic (e.g., DDI) and intrinsic (e.g., hepatic cirrhosis, CYP genetic) factors on drug exposure supporting the development of the drug candidate.